CVS vs DBD · P/E 16, rev $402.07B vs P/E 28, rev $3.75B
CVS Health Corp (CVS) versus Diebold Nixdorf, Incorporated (DBD) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Diebold Nixdorf, Incorporated (DBD) is a software - application company listed on US.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported DBD revenue for 2024-12-31 was $3.75B. Net income was -$14.5M. Revenue was up 130.3% from 2023-12-31 to 2024-12-31. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. DBD currently screens at market cap $2.82B and trailing P/E 28.1.
Not investment advice. Open the CVS and DBD stock pages for the full models.
Not investment advice.